Page 107 - NAME OF CONDITION: REFRACTIVE ERRORS

Prostaglan Increased uveoscleral 25-33% Cystoids macular edema Macular edema
dins outflow conjunctival injection history of herpes
periocular keratitis
hyperpigmentation
eyelash growth
iris colour change, uveitis
possible herpes virus
reactivation

Beta- Decreased aqueous 20-25% Corneal toxicity COPD, asthma,
blockers production allergic reactions bradycardia, first
congestive heart failure degree heart block,
bronchospasm Myasthenia gravis
bradycardia CHF, hypotension
depression
impotence
Alpha- Non-selective: 20-25% Conjuctival injection, Monoamino oxide
adrenergic improve aqueous allergic reaction, inhibitor therapy
agonists outflow somnolosence, fatigue, infants and children
Selective: decrease headache <2 yrs
aqueous production,
decrease episcleral
venous pressure,
increase uveoscleral
outflow
Carbonic Decrease aqueous 15- 20% Topical use: metallic taste Sulfonamide allergy,
anhydrase production Corneal edema, allergic aplastic anemia, Renal
inhibitors dermatoconjunctivitis, calculi and Renal
Systemic use: Steven failure, sickle cell
Johnson syndrome, disease
aplastic anemaia,
thrombocytopenia, renal
calculi,metallic taste,
malaise, anorexia, gastric
irritation, depression,
serum electrolyte
disturbance
Parasyma Increased trabecular 20-25% Myopia, brow ache, Neovascular
pathomim outflow decreased vision, cataract, glaucoma, malignant
metic corneal toxicity, glaucoma, periodic
agents dermatoconjunctivitis, retinal evaluation
uveitis, development of
peripheral anterior
synechiae.

107